Gentium S.p.A. Reports Second Quarter Financial Results; Provides Phase II/III Pediatric Prevention Trial and Financial Update

December 18, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

VILLA GUARDIA, Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ: GENT) (the “Company”) today provided an update regarding the Phase II/III pediatric prevention trial and reported financial results for the quarter ended June 30, 2008.

Twitter
LinkedIn
Facebook
Email
Print